Chinese drugs giant, Shenzhen team up to invest in city’s biomedical start-ups
Fosun Pharma will team up with Shenzhen’s government to raise a 5-billion yuan (US$700 million) healthcare fund to invest in start-ups and innovations in cellular biology, genetics and other fields related to biomedicine.